Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir/Ritonavir”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04307693
What this trial is testing

Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Asan Medical Center 65
Large-scale testing (Phase 3)Study completedNCT01237444
What this trial is testing

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Who this might be right for
HIV Infection
Pedro Cahn 417
Early research (Phase 1)Study completedNCT02159352
What this trial is testing

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 49
Not applicableStudy completedNCT00028314
What this trial is testing

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Who this might be right for
HIV InfectionsLipodystrophyWasting Disease
National Institute of Allergy and Infectious Diseases (NIAID) 150
Not applicableStudy completedNCT00041964
What this trial is testing

HIV Levels During Pregnancy and After Childbirth

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 129
Post-approval studies (Phase 4)Ended earlyNCT00775606
What this trial is testing

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Who this might be right for
Acquired Immune Deficiency Syndrome
Rush University Medical Center 15
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Study completedNCT00946595
What this trial is testing

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 420
Large-scale testing (Phase 3)Study completedNCT00004581
What this trial is testing

Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Abbott 300
Not applicableUnknownNCT00578825
What this trial is testing

A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome

Who this might be right for
Severe Acute Respiratory Syndrome
Hospital Authority, Hong Kong 340
Not applicableStudy completedNCT00050908
What this trial is testing

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT00038220
What this trial is testing

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Who this might be right for
HIV Infections
Abbott 40
Large-scale testing (Phase 3)Study completedNCT00978068
What this trial is testing

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Who this might be right for
MalariaHIV Infections
University of California, San Francisco 176
Early research (Phase 1)Study completedNCT00985543
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Who this might be right for
Acquired Immunodeficiency Syndrome
Kirby Institute 22
Testing effectiveness (Phase 2)Study completedNCT00043953
What this trial is testing

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Who this might be right for
HIV Infections
Abbott 30
Post-approval studies (Phase 4)Study completedNCT00103012
What this trial is testing

Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 47
Post-approval studies (Phase 4)Study completedNCT01471821
What this trial is testing

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Who this might be right for
HIV Infection
Juan A. Arnaiz 250
Testing effectiveness (Phase 2)Study completedNCT00036452
What this trial is testing

Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 402
Not applicableStudy completedNCT00004855
What this trial is testing

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT01076179
What this trial is testing

Kaletra in Combination With Antiretroviral Agents

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 502
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation